Deck 5 Bioproducts has developed an innovative process to streamline development and manufacture of reagents for virology research.

We develop and manufacture high quality reagents that allow the study, analysis and detection of viral nucleic acids, proteins and host immune responses to the virus. This is accomplished using a streamlined process starting with an electronic sequence of a viral gene through gene synthesis, protein expression and antibody generation.

That means we are:

• Better - With the use of synthetics in our development process, our products are not susceptible to impurities that are common to current methods of reagent development. Consequently, our customers receive the highest quality product and broadest product line available.
• Faster - With current delivery times for viral reagents ranging from one week to six months, Deck 5’s ability to deliver products within 24 hours is a significant breakthrough for the scientific community shortening the delivery times for life saving medicines to be developed.
• Cheaper - Low biosafety level requirements enable Deck 5 to operate in a more advantageous environment than the competition, resulting in improved operational efficiency, cost savings for researchers and greater financial return for shareholders.